NBC 10 News Today: Bird Flu Mutation in Louisiana
NBC 10 News Today: Bird Flu Mutation in Louisiana
Related Articles
Towards Prevention of Psoriatic Arthritis in Patients With Psoriasis – Physician’s Weekly
Risk factors for patients with psoriasis developing psoriatic arthritis, and potential pharmacological and non-pharmacological interventions.
Daniel Dines, UiPath CEO & Founder: Why Agents Do Not Mean RPA is F*** | E1240
Daniel Dines is the Founder & CEO at UiPath, one of the most incredible journeys in startups. For 10 years, UiPath was a bootstrapped company…
Office Hours with Earth’s Virology Professor Livestream 1/8/25 8 pm EDT
Join Vincent Racaniello for Office Hours to answer your questions about viruses – including SARS-CoV-2, Mpox virus, poliovirus, influenza virus, and more – o…
Greenland, oil and ‘all hell’ in the Middle East: Takeaways from Trump’s Mar-a-Lago press conference
From a new era of American imperialism to an enduring bitterness toward a criminal justice system he maintains unfairly targeted him, here are our top…
Two Iconic Malibu Restaurants Have Been Destroyed by the Palisades Wildfire
Reel Inn and Cholada Thai were reportedly destroyed by the fast-growing fire on January 7, 2025
Prolonged sauna exposure without adequate hydration linked to heat stroke risk
Basking too long in a sauna may put bathers at risk of heat stroke, particularly if they haven’t drunk enough water beforehand, warn doctors in…
Femoral or Radial Secondary Access in TAVR: A Subanalysis From the Multicenter PULSE Registry
AbstractBackgroundTransradial secondary access (TR-SA) may serve as an alternative to the traditional femoral secondary access (TF-SA) for pigtail placement in transcatheter aortic valve replacemen…
Evergreen Nephrology Plans Expansion With $130 Million in New Capital | Docwire News
Evergreen Nephrology has raised $130 million in capital to expand its value-based care model for kidney disease.
Novel JAK2 Inhibitor for Polycythemia Vera Receives Orphan Drug Designation | Blood Cancers Today
The FDA has granted the Orphan Drug Designation to VGT-1849A, a novel JAK2 inhibitor for the treatment of patients with polycythemia vera.
Molecularly Targeted Therapies in Oncology: Episode 4
Website: https://www.onclive.comTwitter: https://twitter.com/OncLiveFacebook: https://www.facebook.com/OncLive/LinkedIn: https://www.linkedin.com/company/onc…
